Constine LS, et al. The role of radiation therapy in patients with relapsed or refractory Hodgkin lymphoma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018;100(5):1100–18.

Article  PubMed  Google Scholar 

Ng AK, et al. Role of radiation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018;100(3):652–69.

Article  PubMed  Google Scholar 

Radford J, et al. Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma. N Engl J Med. 2015;372(17):1598–607.

Article  CAS  PubMed  Google Scholar 

Press OW, et al. US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose–positron emission tomography imaging: Southwest Oncology Group S0816. J Clin Oncol. 2016;34(17):2020–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vargo JA, et al. Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: do we still need consolidative radiotherapy? J Clin Oncol. 2015;33(32):3710–7.

Article  CAS  PubMed  Google Scholar 

National Comprehensive Cancer, N., NCCN clinical practice guidelines in oncology (NCCN Guidelines): B-cell lymphomas. National Comprehensive Cancer Network, 2019.

Younes A, et al. International working group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol. 2017;28(7):1436–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–67.

Article  PubMed  PubMed Central  Google Scholar 

Crump M, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood J American Soc Hematol. 2017;130(16):1800–8.

CAS  Google Scholar 

Fermé C, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N Engl J Med. 2007;357(19):1916–27.

Article  PubMed  Google Scholar 

Engert A, et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin’s lymphoma: results of the HD8 trial of the German Hodgkin’s Lymphoma Study Group. J Clin Oncol. 2003;21(19):3601–8.

Article  PubMed  Google Scholar 

Girinsky T, et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol. 2006;79(3):270–7.

Article  PubMed  Google Scholar 

André MPE, et al. Early positron emission tomography response–adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 2017;35(16):1786–94.

Article  PubMed  Google Scholar 

Specht L, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89(4):854–62.

Article  PubMed  Google Scholar 

Illidge T, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma—target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2014;89(1):49–58.

Article  PubMed  Google Scholar 

Josting A, et al. Salvage radiotherapy in patients with relapsed and refractory Hodgkin’s lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. J Clin Oncol. 2005;23(7):1522–9.

Article  PubMed  Google Scholar 

Murray L, et al. Involved node, site, field and residual volume radiotherapy for lymphoma: a comparison of organ at risk dosimetry and second malignancy risks. Clin Oncol. 2015;27(7):401–10.

Article  CAS  Google Scholar 

Wirth A, et al. Involved site radiation therapy in adult lymphomas: an overview of international lymphoma radiation oncology group guidelines. Int J Radiat Oncol Biol Phys. 2020;107(5):909–33.

Article  PubMed  Google Scholar 

Lamy T, et al. R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood. 2018;131(2):174–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brooks ED, Fang P, Pinnix CC. Salvage radiotherapy for primary refractory and relapsed diffuse large B-cell lymphoma. Br J Radiol. 2021;94(1127):20210360.

Article  PubMed  PubMed Central  Google Scholar 

Freeman CL, et al. Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2021;137(7):929–38.

Article  CAS  PubMed  Google Scholar 

Shaikh PM, et al. Consolidation radiotherapy following positron emission tomography complete response in early-stage Hodgkin lymphoma: a meta-analysis. Leuk Lymphoma. 2020;61(7):1610–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson PWM, et al. Consolidation radiotherapy in patients with advanced Hodgkin’s lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519). J Clin Oncol. 2010;28(20):3352–9.

Article  PubMed  Google Scholar 

Eichenauer DA, et al. Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. J Clin Oncol. 2020;38(7):698–705.

Article  PubMed  Google Scholar 

Danilov AV, et al. Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 phase 2 trial. Leuk Lymphoma. 2017;58(2):461–5.

Article  PubMed  Google Scholar